Cargando…

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease

OBJECTIVE: To determine the inflammatory analytes that predict clinical progression and evaluate their performance against biomarkers of neurodegeneration. METHODS: A longitudinal study of MCI‐AD patients in a Discovery cohort over 15 months, with replication in the Alzheimer’s Disease Neuroimaging...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pillai, Jagan A., Bena, James, Bebek, Gurkan, Bekris, Lynn M., Bonner‐Jackson, Aaron, Kou, Lei, Pai, Akshay, Sørensen, Lauge, Neilsen, Mads, Rao, Stephen M., Chance, Mark, Lamb, Bruce T., Leverenz, James B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359114/ https://www.ncbi.nlm.nih.gov/pubmed/32634865 http://dx.doi.org/10.1002/acn3.51109

Ejemplares similares

Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2019)

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
por: Pillai, Jagan A., et al.
Publicado: (2023)

Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes
por: Pillai, Jagan A., et al.
Publicado: (2021)

TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease
por: Pillai, Jagan A., et al.
Publicado: (2021)

Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer’s and Lewy body neuropathology
por: Pillai, Jagan A., et al.
Publicado: (2021)

Association of Variation in Behavioral Symptoms With Initial Cognitive Phenotype in Adults With Dementia Confirmed by Neuropathology
por: Pillai, Jagan A., et al.
Publicado: (2022)

The Media Coverage of Bruce Willis Reveals Unfamiliarity With Frontotemporal Degeneration
por: Hurley, Robert S, et al.
Publicado: (2023)

Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease
por: Uchida, Atsuro, et al.
Publicado: (2018)

Brain region’s relative proximity as marker for Alzheimer’s disease based on structural MRI
por: Lillemark, Lene, et al.
Publicado: (2014)

PETALS: Proteomic Evaluation and Topological Analysis of a mutated Locus' Signaling
por: Bebek, Gurkan, et al.
Publicado: (2010)

Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry()
por: Sørensen, Lauge, et al.
Publicado: (2016)

Association of Anxiety Awareness with Risk Factors of Cognitive Decline in MCI
por: Gigi, Ariela, et al.
Publicado: (2021)

MAGNET: MicroArray Gene expression and Network Evaluation Toolkit
por: Linderman, George C., et al.
Publicado: (2012)

Big Data Analytics for Mass Casualty Incident (MCI) Situational Awareness
por: Ordun, Catherine, et al.
Publicado: (2015)

Longitudinal change in regional brain volumes with exposure to repetitive head impacts
por: Bernick, Charles, et al.
Publicado: (2020)

The Alzheimer's Cell Atlas (TACA): A single‐cell molecular map for translational therapeutics accelerator in Alzheimer's disease
por: Zhou, Yadi, et al.
Publicado: (2022)

Neuropsychological comparison of incident MCI and prevalent MCI
por: Hansen, Allison, et al.
Publicado: (2018)

AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer’s drug discovery
por: Zhou, Yadi, et al.
Publicado: (2021)

In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
por: Hessen, Erik, et al.
Publicado: (2019)

Structural Correlates of Personality Dimensions in Healthy Aging and MCI
por: Rodriguez, Cristelle, et al.
Publicado: (2019)

Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
por: Rao, Rammohan V., et al.
Publicado: (2023)

Correlation between brain volume and retinal photoreceptor outer segment volume in normal aging and neurodegenerative diseases
por: Uchida, Atsuro, et al.
Publicado: (2020)

Prediction and Testing of Biological Networks Underlying Intestinal Cancer
por: Patel, Vishal N., et al.
Publicado: (2010)

Neuroanatomical and Neuropsychological Markers of Amnestic MCI: A Three-Year Longitudinal Study in Individuals Unaware of Cognitive Decline
por: Goerlich, Katharina S., et al.
Publicado: (2017)

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients
por: Aksu, Yaman, et al.
Publicado: (2011)

Microcystin mcyA and mcyE Gene Abundances Are Not Appropriate Indicators of Microcystin Concentrations in Lakes
por: Beversdorf, Lucas J., et al.
Publicado: (2015)

PathFinder: mining signal transduction pathway segments from protein-protein interaction networks
por: Bebek, Gurkan, et al.
Publicado: (2007)

Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time
por: Hendrix, Suzanne B
Publicado: (2012)

The Test Your Memory for Mild Cognitive Impairment (TYM-MCI)
por: Brown, Jeremy M, et al.
Publicado: (2017)

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD
por: Fessel, Jeffrey
Publicado: (2020)

Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway
por: Strand, Bjørn Heine, et al.
Publicado: (2018)

Focal white matter disruptions along the cingulum tract explain cognitive decline in amnestic mild cognitive impairment (aMCI)
por: Gozdas, Elveda, et al.
Publicado: (2020)

Microenvironmental genomic alterations reveal signaling networks for head and neck squamous cell carcinoma
por: Bebek, Gurkan, et al.
Publicado: (2011)

Understanding the subjective experiences of memory concern and MCI diagnosis: A scoping review
por: Carter, Christine, et al.
Publicado: (2022)

Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease
por: Xu, Jielin, et al.
Publicado: (2021)

Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals
por: d'Oleire Uquillas, Federico, et al.
Publicado: (2017)

Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging
por: Ottoy, Julie, et al.
Publicado: (2019)

Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study
por: Lin, Chieh-Hsin, et al.
Publicado: (2021)

Study on QSTR of Benzoic Acid Compounds with MCI
por: Li, Zuojing, et al.
Publicado: (2010)

Executive Dysfunction in MCI: Subtype or Early Symptom
por: Reinvang, Ivar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uufbdspspopbmoc2r77rgigqm2